Frontotemporal dementia (FTD) is a group of heterogeneous sporadic and familial neurodegenerative disorders. Approximately half of the patients with FTD develop abundant tau pathologies in neurons and glia. The familial counterpart of this group of FTDs is known as frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17) which includes patients with phenotypes similar to sporadic disorders like progressive supranuclear palsy (PSP), Pick's disease (PiD), cortical basal degeneration (CBD), and argyrophilic grains disease (AGD). In contrast to FTD characterized by prominent tau pathologies, the brains of the remaining FTD patients either lack distinctive neuropathological lesions, referred to as dementia lacking distinctive histopathology (DLDH) or show ubiquitin-positive, but tau and alpha-synuclein (alpha-syn) negative inclusions with or without motor neuron disease (FTD-MND). To clarify similarities and differences among mechanisms underlying FTDs, the goals of Project 3 are to characterize the neuropathology of FTDs using biochemical, immunohistochemical and ultrastructural methods with specific emphasis on testing the hypothesis that cofactors such as alpha-syn, heparan sulfate, or oxidants play distinct roles in regulating tau pathologies including the isoform composition of tau lesions. Other studies will determine if amino or carboxy-terminal truncated tau fragments serve as """"""""seeds"""""""" to facilitate tau fibrillization. Finally, to further investigate the etiology and pathogenesis of distinct FTDs, Project 3 also will examine FTD-MND by isolating the ubiquitin-positive, tau and alpha-syn negative inclusions and determining the protein building blocks of these inclusions. Successful completion of the studies proposed in Project 3 will address fundamental disease mechanisms of FTDs, which, in conjunction with research advances from other projects in this Program Project Grant will accelerate efforts to find better therapeutic interventions for patients with diverse FTDs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG017586-07
Application #
7309854
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-03-01
Budget End
2007-02-28
Support Year
7
Fiscal Year
2006
Total Cost
$322,809
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Phillips, Jeffrey S; Das, Sandhitsu R; McMillan, Corey T et al. (2018) Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease. Hum Brain Mapp 39:691-708
Smith, Kara M; Ash, Sharon; Xie, Sharon X et al. (2018) Evaluation of Linguistic Markers of Word-Finding Difficulty and Cognition in Parkinson's Disease. J Speech Lang Hear Res 61:1691-1699
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Gangishetti, Umesh; Christina Howell, J; Perrin, Richard J et al. (2018) Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimers Res Ther 10:98
Lee, Edward B (2018) Integrated neurodegenerative disease autopsy diagnosis. Acta Neuropathol 135:643-646
Besser, Lilah; Kukull, Walter; Knopman, David S et al. (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord 32:351-358
Rennert, Lior; Xie, Sharon X (2018) Cox regression model with doubly truncated data. Biometrics 74:725-733
Sandelius, Åsa; Portelius, Erik; Källén, Åsa et al. (2018) Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology. Alzheimers Dement :
Adler, Daniel H; Wisse, Laura E M; Ittyerah, Ranjit et al. (2018) Characterizing the human hippocampus in aging and Alzheimer's disease using a computational atlas derived from ex vivo MRI and histology. Proc Natl Acad Sci U S A 115:4252-4257
Gibbons, Garrett S; Banks, Rachel A; Kim, Bumjin et al. (2018) Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies. J Neuropathol Exp Neurol 77:216-228

Showing the most recent 10 out of 593 publications